Items Tagged ‘Lung Cancer’

June 15th, 2012

Afatinib Delays Progression of Advanced Lung Cancer


Initial treatment with the targeted drug afatinib prolongs progression-free survival in patients with EGFR-positive advanced lung cancer when compared with standard chemotherapy, according to the results of a study presented at the 2012 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Illinois. Lung cancer remains the leading cause of cancer death […]

View full entry

Tags: Lung Cancer, Lung Cancer - Non-Small Cell, News, Stages IIIB-IV Lung Cancer - Non-Small Cell